4.7 Article

Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 52-week results from a randomized controlled trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Endocrinology & Metabolism

Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes

Marc Evans et al.

DIABETES THERAPY (2020)

Review Endocrinology & Metabolism

SGLT inhibitor adjunct therapy in type 1 diabetes

Rory J. McCrimmon et al.

DIABETOLOGIA (2018)

Article Endocrinology & Metabolism

Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients with Type 2 Diabetes: A Randomized Controlled Trial

Robert R. Henry et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2018)

Editorial Material Endocrinology & Metabolism

SGLT Inhibitors for Type 1 Diabetes: An Obvious Choice or Too Good to Be True?

Matthew C. Riddle et al.

DIABETES CARE (2018)

Article Endocrinology & Metabolism

Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials

Julio Rosenstock et al.

DIABETES CARE (2018)

Article Endocrinology & Metabolism

International Consensus on Use of Continuous Glucose Monitoring

Thomas Danne et al.

DIABETES CARE (2017)

Article Endocrinology & Metabolism

Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association

Jane L. Chiang et al.

DIABETES CARE (2014)

Review Endocrinology & Metabolism

Hypoglycemia, Diabetes, and Cardiovascular Events

Cyrus V. Desouza et al.

DIABETES CARE (2010)

Article Endocrinology & Metabolism

Hyperglycemic Crises in Adult Patients with Diabetes

Abbas E. Kitabchi et al.

DIABETES CARE (2009)

Review Endocrinology & Metabolism

Insulin-associated weight gain in diabetes - causes, effects and coping strategies

David Russell-Jones et al.

DIABETES OBESITY & METABOLISM (2007)

Review Endocrinology & Metabolism

Hypoglycemia in diabetes

PE Cryer et al.

DIABETES CARE (2003)